A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis

• Päätekijät: Gaurav Agnihotri (Tekijä), Katherine Shi (Tekijä), Peter A. Lio (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Adis, Springer Healthcare, 2019-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Dupilumab, a monoclonal antibody that inhibits both interleukin (IL)-4 and IL-13 signaling, is an effective treatment option in moderate-to-severe atopic dermatitis (AD). Patients with AD are already at increased risk of developing conjunctivitis, and clinical trials and case reports have s...